Michael Craig Pine Eye Point Pharmaceuticals, Inc. (EYPT) insider trading activity

EYPT Quotes by TradingView

Michael Craig Pine is Chief Corp Dev.&Strat. Officer of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 13,662 shares of EYPT, which is worth approximately $97,000. The most recent transaction as insider was on Jan 06, 2024, when has been sold 5,966 shares (Common Stock) at a price of $20.4 per share, resulting in proceeds of $121,706. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.7K
0% 3M change
155.7% 12M change
Total Value Held $97,000

Michael Craig Pine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2024
SELL
Payment of exercise price or tax liability
$121,706 $20.4 p/Share
5,966 Reduced 30.4%
13,662 Common Stock
Jan 06 2024
BUY
Exercise of conversion of derivative security
-
15,285 Added 43.78%
19,628 Common Stock
Dec 04 2023
SELL
Open market or private sale
$990,000 $22.0 p/Share
45,000 Reduced 89.39%
5,343 Common Stock
Dec 04 2023
BUY
Exercise of conversion of derivative security
$567,900 $12.62 p/Share
45,000 Added 47.2%
50,343 Common Stock
Mar 14 2022
BUY
Open market or private purchase
$12,210 $12.21 p/Share
1,000 Added 50.0%
1,000 Common Stock
MCP

Michael Craig Pine

Chief Corp Dev.&Strat. Officer
Watertown, MA

Track Institutional and Insider Activities on EYPT

Follow EyePoint Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EYPT